MRMD
MariMed Inc.·Healthcare
0.07
4.435%(+0.00)
Close PriceLast Updated: — ET
52W L: $0.0652W H: $0.23
MRMD NEWS
seekingalpha.com
Mar 12
MariMed Inc. (MRMD) Q4 2025 Earnings Call Transcript
MariMed Inc. (MRMD) Q4 2025 Earnings Call Transcript
globenewswire.com
Mar 11
MariMed Reports Fourth Quarter and Full Year 2025 Earnings
NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial results for the fourth quarter and year ended December 31, 2025.
globenewswire.com
Mar 2
MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure
NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today that it has entered into a Restructuring and Exchange Agreement (the “Agreement”) with the holders (the “Holders”) of its $14.725 million Series B Convertible Preferred Stock (the “Series B Obligation”).
globenewswire.com
Feb 11
MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date
NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close.
defenseworld.net
Feb 9
MariMed (OTCMKTS:MRMD) versus Brainsway (NASDAQ:BWAY) Head-To-Head Review
Brainsway (NASDAQ: BWAY - Get Free Report) and MariMed (OTCMKTS:MRMD - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends. Risk and Volatility Brainsway has a beta of 1.2,
